☆ 4.6 Article

Should Impulse Control Disorders and Dopamine Dysregulation Syndrome Be Indications for Deep Brain Stimulation and Intestinal Levodopa?

MOVEMENT DISORDERS (2013)

期刊

MOVEMENT DISORDERS

卷 28, 期 14, 页码 1915-1919

出版社

WILEY

DOI: 10.1002/mds.25735

关键词

-

类别

Clinical Neurology

资金

NINDS NIH HHS [K23 NS044997] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Multidisciplinary Sciences

Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease

Annalisa Gessani, Francesco Cavallieri, Valentina Fioravanti, Isabella Campanini, Andrea Merlo, Giulia Di Rauso, Benedetta Damiano, Sara Scaltriti, Elisa Bardi, Maria Giulia Corni, Francesca Antonelli, Francesca Cavalleri, Maria Angela Molinari, Sara Contardi, Elisa Menozzi, Alessandro Fraternali, Annibale Versari, Giuseppe Biagini, Valerie Fraix, Serge Pinto, Elena Moro, Carla Budriesi, Franco Valzania

Summary: This study evaluated the long-term effects of bilateral STN-DBS on speech in advanced PD patients. The results showed that speech intelligibility remained at the same level as preoperative values in the long-term, and STN-DBS led to a significant improvement in speech intelligibility in the postoperative assessment.

SCIENTIFIC REPORTS (2023)

添加到收藏夹

Article Clinical Neurology

A circuit-based approach to modulate hypersexuality in Parkinson's disease

David Mata-Marin, Jose angel Pineda-Pardo, Mario Michiels, Cristina Pagge, Claudia Ammann, Raul Martinez-Fernandez, Jose Antonio Molina, Lydia Vela-Desojo, Fernando Alonso-Frech, Ignacio Obeso

Summary: This study provides evidence for the balance between enhanced desire towards reward and cognitive control deficits in patients with impulse-control disorder, specifically hypersexuality, in Parkinson's disease under dopamine replacement therapy. The study also identifies the underlying fronto-striatal and mesolimbic circuitry involved in uncontrollable sexual responses and demonstrates that cortical neuromodulation can alleviate this symptom.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Should Treatment Indications for Chronic Hepatitis B Be Expanded?

Wen-Juei Jeng, Anna S. Lok

Summary: Current treatment for chronic hepatitis B virus (HBV) does not eradicate the virus, requiring long-term maintenance for most patients. Expanding treatment to certain patient populations, such as immune tolerant patients and those with evidence of liver disease, is supported by available evidence. However, data supporting treatment expansion for confirmed inactive carriers and other immune tolerant patients is lacking. New therapies that can achieve HBsAg loss in a high percentage of patients after a finite course of treatment may allow for more liberal HBV treatment indications in the future.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Initiating dopamine agonists rather than levodopa in early Parkinson's disease does not delay the need for deep brain stimulation

Diana A. Olszewska, Alfonso Fasano, Renato P. Munhoz, Carolina Candelaria Ramirez Gomez, Anthony E. Lang

Summary: This retrospective cohort study aimed to investigate the difference in the time between initial levodopa and dopamine agonist (DA) treatment and the development of disabling motor complications (MCs) in Parkinson's disease (PD) patients who underwent deep brain stimulation (DBS). The results showed no significant difference in the duration from the first treatment to DBS assessment or surgery between patients who received levodopa and those who received a DA.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's

Annalisa Gessani, Francesco Cavallieri, Valentina Fioravanti, Isabella Campanini, Andrea Merlo, Giulia Di Rauso, Benedetta Damiano, Sara Scaltriti, Elisa Bardi, Maria Giulia Corni, Francesca Antonelli, Francesca Cavalleri, Maria Angela Molinari, Sara Contardi, Elisa Menozzi, Alessandro Fraternali, Annibale Versari, Giuseppe Biagini, Valerie Fraix, Serge Pinto, Elena Moro, Carla Budriesi, Franco Valzania

Summary: This study aimed to evaluate the long-term effects of bilateral subthalamic nucleus deep brain stimulation (STN-DBS) on speech in advanced Parkinson's Disease (PD) patients. The results showed that speech intelligibility stayed at the same level as preoperative values in the long-term follow-up. However, there was a significant acute improvement of speech intelligibility in the postoperative assessment.

SCIENTIFIC REPORTS (2023)

添加到收藏夹

Article Clinical Neurology

Predictors of dopamine dysregulation syndrome in patients with early Parkinson's disease

Keke Liang, Xiaohuan Li, Jianjun Ma, Hongqi Yang, Xiaoxue Shi, Yongyan Fan, Dawei Yang, Dashuai Guo, Chuanze Liu, Linrui Dong, Qingqing Chang, Qi Gu, Siyuan Chen, Dongsheng Li

Summary: In this study, the incidence of and risk factors for dopamine dysregulation syndrome (DDS) in patients with early Parkinson's disease (PD) were explored. It was found that early PD patients with hypersexuality, compulsive eating, compulsive shopping, anxiety, and lower Hoehn-Yahr stage were at increased risk for DDS. Early identification of risk factors for DDS is crucial for improving the quality of life of PD patients.

NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Article Multidisciplinary Sciences

No effect of subthalamic deep brain stimulation on metacognition in Parkinson's disease

Carlos Trenado, Matthias Boschheidgen, Karim N'Diaye, Alfons Schnitzler, Luc Mallet, Lars Wojtecki

Summary: Deep brain stimulation of the subthalamic nucleus (STN-DBS) is effective in treating motor symptoms in Parkinson's disease (PD), but its impact on high cognitive processes such as metacognition remains unclear. This study found no significant effect of STN-DBS on reversal learning (RL) or metacognition.

SCIENTIFIC REPORTS (2023)

添加到收藏夹

Editorial Material Health Care Sciences & Services

Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?

Kenneth Blum, Catherine A. Dennen, Igor Elman, Abdalla Bowirrat, Panayotis K. Thanos, Rajendra D. Badgaiyan, B. William Downs, Debasis Bagchi, David Baron, Eric R. Braverman, Ashim Gupta, Richard Green, Thomas McLaughlin, Debmalya Barh, Mark S. Gold

Summary: Reward Deficiency Syndrome (RDS) is a syndrome characterized by a breakdown of reward neurotransmission, resulting in various addictive, compulsive, and impulsive behaviors. RDS is associated with a lack of integration between perception, cognition, and emotions, caused by significant dopaminergic surges and hypo-functionality of glutamatergic neurotransmission. There is a significant risk of dopaminergic gene polymorphic allele overlap between RDS, depression, and subsets of schizophrenia. Repairing the hypodopaminergia causing addictive behaviors may involve precision DNA-guided therapy using the Genetic Addiction Risk Severity (GARS) test and a specific nutraceutical formulation.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Clinical Neurology

Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure

Claudia Sagheddu, Francesco Traccis, Valeria Serra, Mauro Congiu, Roberto Frau, Joseph F. Cheer, Miriam Melis

Summary: Male rat offspring prenatally exposed to THC exhibit reduced VTA dopamine neuron activity and enhanced sensitivity to D2 receptor activation, leading to compromised sensorimotor gating functions. This makes them susceptible to subsequent challenges that may trigger psychotic-like outcomes.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

Mental Health Care Should Be Available for All, Not a Luxury

Sarah Sloat

Summary: The stress from COVID-19 worsened the existing flaws in the system, causing it to collapse.

NATURE (2022)

添加到收藏夹

Article Clinical Neurology

Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease

Sara C. Staubo, Ole Martin Fuskevag, Mathias Toft, Ingeborg H. Lie, Kirsti M. J. Alvik, Pal Jostad, Stein H. Tingvoll, Hallvard Lilleng, Kristina Rosqvist, Elisabet Storset, Per Odin, Espen Dietrichs, Erik Sveberg Dietrichs

Summary: The study suggests that the occurrence of impulse control disorders (ICDs) among patients using ropinirole is dependent on serum concentration and drug exposure, while the use of pramipexole may inherently increase ICD risk.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

A case-control study investigating food addiction in Parkinson patients

Ingrid de Chazeron, F. Durif, C. Lambert, I Chereau-Boudet, M. L. Fantini, A. Marques, P. Derost, B. Debilly, G. Brousse, Y. Boirie, P. M. Llorca

Summary: The study found that patients with Parkinson's disease have a higher prevalence of food addiction and night eating syndrome, which are associated with female gender and impulsivity, but not with dopaminergic therapy.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Clinical Neurology

Levodopa Versus Dopamine Agonist After Subthalamic Stimulation in Parkinson's Disease

Marina Picillo, Onanong Phokaewvarangkul, Yu-Yan Poon, Cameron C. McIntyre, Sinem Balta Beylergil, Renato P. Munhoz, Suneil K. Kalia, Mojgan Hodaie, Andres M. Lozano, Alfonso Fasano

Summary: This study compared the efficacy and safety of levodopa versus dopamine agonist monotherapy after deep brain stimulation in Parkinson's disease. Results showed that in short- and mid-term follow-up, more than half of patients were able to safely continue monotherapy, with levodopa patients having a higher likelihood. In the long term, only a minority of patients were able to maintain levodopa monotherapy, while dopamine agonist monotherapy was not well tolerated.

MOVEMENT DISORDERS (2021)

添加到收藏夹

Editorial Material Obstetrics & Gynecology

Why ovarian stimulation should be aimed to maximize oocyte yield

Baris Ata

Summary: The ultimate measure of success in assisted reproductive technology (ART) is the cumulative live birth rate per ovarian stimulation cycle. Ovarian stimulation has adverse effects on endometrial receptivity and increases the risks of ovarian hyperstimulation syndrome and adverse obstetric and neonatal outcomes. Mild stimulation has been proposed as a safer and cost-effective alternative. However, accumulating data show that ovarian stimulation has no adverse effects and preventive strategies have been introduced. Vitrification allows for cycle segmentation and maximizes the contribution of every oocyte to the cumulative live birth rate.

REPRODUCTIVE BIOMEDICINE ONLINE (2023)

添加到收藏夹

Article Clinical Neurology

Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program

Olivier Corbeil, Stephanie Corbeil, Michel Dorval, Pierre-Hugues Carmichael, Isabelle Giroux, Christian Jacques, Marie-France Demers, Marc-Andre Roy

Summary: This study found that individuals with first-episode psychosis and a history of gambling are at increased risk of developing problem gambling when receiving aripiprazole. The results emphasize the importance of systematically screening for problem gambling in all individuals with psychotic disorders, as this comorbidity hinders recovery.

CNS DRUGS (2021)

添加到收藏夹

Article Geriatrics & Gerontology

Medicare Claims Data Underestimate Hallucinations in Older Adults With Dementia

Ali G. Hamedani, Daniel Weintraub, Allison W. Willis

Summary: The sensitivity of ICD codes for identifying dementia-related hallucinations is low, while specificity and predictive values are higher. Estimates of the prevalence and outcomes of dementia-related hallucinations using administrative claims data are likely to be biased.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2022)

添加到收藏夹

Review Medicine, General & Internal

Management of psychiatric and cognitive complications in Parkinson's disease

Daniel Weintraub, Dag Aarsland, Roberta Biundo, Roseanne Dobkin, Jennifer Goldman, Simon Lewis

Summary: Neuropsychiatric symptoms in Parkinson's disease are often under-recognized and under-treated, but their management is crucial. Understanding the epidemiology, presentation, risk factors, neural substrate, and treatment strategies is important.

BMJ-BRITISH MEDICAL JOURNAL (2022)

添加到收藏夹

Article Clinical Neurology

Plasma phosphorylated tau181 predicts cognitive and functional decline

Thomas F. Tropea, Teresa Waligorska, Sharon X. Xie, Ilya M. Nasrallah, Katheryn A. Q. Cousins, John Q. Trojanowski, Murray Grossman, David J. Irwin, Daniel Weintraub, Edward B. Lee, David A. Wolk, Alice S. Chen-Plotkin, Leslie M. Shaw

Summary: The objective of this study was to determine if plasma tau phosphorylated at threonine 181 (p-tau181) can distinguish Alzheimer's disease (AD) from normal cognition (NC) in adults, predict cognitive and functional decline, and validate findings in an external cohort. The results showed that plasma p-tau181 can accurately differentiate AD pathology from NC, and higher levels of p-tau181 are associated with faster cognitive and functional decline.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated

John L. Robinson, Sharon X. Xie, Daniel R. Baer, EunRan Suh, Vivianna M. Van Deerlin, Nicholas J. Loh, David J. Irwin, Corey T. McMillan, David A. Wolk, Alice Chen-Plotkin, Daniel Weintraub, Theresa Schuck, Virginia M. Y. Lee, John Q. Trojanowski, Edward B. Lee

Summary: In this retrospective study, the incidence of 10 pathologies in neurodegenerative disease (ND) and normal aging was examined, with up to seven pathologies observed concurrently resulting in 161 different combinations. The presence of multiple additive pathologies was associated with factors such as longer disease duration, clinical dementia, older age, and APOE e4 status.

BRAIN (2023)

添加到收藏夹

Article Clinical Neurology

Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies

Danielle S. Abraham, Thanh Phuong Pham Nguyen, Leah J. Blank, Dylan Thibault, Shelly L. Gray, Sean Hennessy, Charles E. Leonard, Daniel Weintraub, Allison W. Willis

Summary: This study examined the differential prescribing patterns between new and established treatments for common neurological conditions. Using data from a national sample of US commercially insured adults from 2005-2019, the study compared new users of recently approved medications for three conditions: diabetic peripheral neuropathy, Parkinson disease psychosis, and epilepsy. The results showed that newer medications were more frequently prescribed to individuals with prior treatment, suggesting potential bias in comparative effectiveness and safety studies. The study emphasizes the importance of reporting propensity score non-overlap in comparative studies involving newer medications and suggests methodological approaches to address channeling bias.

NEUROTHERAPEUTICS (2023)

添加到收藏夹

Article Clinical Neurology

Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease

Katheryn A. Q. Cousins, David J. Irwin, Alice Chen-Plotkin, Leslie M. Shaw, Sanaz Arezoumandan, Edward B. Lee, David A. Wolk, Daniel Weintraub, Meredith Spindler, Andres Deik, Murray Grossman, Thomas F. Tropea

Summary: This study found that plasma GFAP may be sensitive to concomitant AD pathology in LBSD, especially accumulation of beta-amyloid plaques.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

添加到收藏夹

Article Neurosciences

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

Kalpana M. Merchant, Tanya Simuni, Janel Fedler, Chelsea Caspell-Garcia, Michael Brumm, Kelly N. H. Nudelman, Elizabeth Tengstrandt, Frank Hsieh, Roy N. Alcalay, Christopher Coffey, Lana Chahine, Tatiana Foroud, Andrew Singleton, Daniel Weintraub, Samantha Hutten, Todd Sherer, Brit Mollenhauer, Andrew Siderowf, Caroline Tanner, Ken Marek

Summary: We quantified concentrations of three isoforms of BMP in different cohorts of Parkinson's disease patients and found that LRRK2 and GBA1 gene mutations were associated with elevated BMP levels. However, BMP is not a prognostic or disease progression biomarker.

NPJ PARKINSONS DISEASE (2023)

添加到收藏夹

Article Neurosciences

Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism

Bradley J. Wilkes, Emily R. Tobin, David J. Arpin, Wei-en Wang, Michael S. Okun, Michael S. Jaffee, Nikolaus R. McFarland, Daniel M. Corcos, David E. Vaillancourt

Summary: Objective measures of disease progression using the Purdue Pegboard Test (PPT) were conducted in patients with Parkinson's disease (PD), atypical Parkinsonism, and healthy controls. The decline in PPT performance in PD patients correlated with motor symptom progression, while no such decline was seen in controls. Neuroimaging measures from the basal ganglia were significant predictors of PPT performance in PD, and cortical, basal ganglia, and cerebellar regions were predictors for atypical Parkinsonism. Accelerometry in PD patients showed diminished acceleration range and irregular patterns, which correlated with PPT scores.

NPJ PARKINSONS DISEASE (2023)

添加到收藏夹

Article Clinical Neurology

Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study

Daniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, Chelsea Caspell-Garcia, Cornelis Blauwendraat, Ethan G. Brown, Lana M. Chahine, Christopher S. Coffey, Roseanne D. Dobkin, Tatiana Foroud, Doug Galasko, Karl Kieburtz, Kenneth Marek, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, Tanya Simuni, Andrew Siderowf, Andrew Singleton, John Seibyl, Caroline M. Tanner

Summary: This study used data from a multi-site, international, prospective cohort study to investigate the impact of dopamine system-related biomarkers on cognitive impairment in Parkinson's disease. The results showed that alterations in the dopamine system were associated with the development of cognitive impairment in Parkinson's disease. If confirmed causative, these findings suggest that the dopamine system is instrumental to cognitive health status throughout the disease course.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

添加到收藏夹

Article Clinical Neurology

What & apos;s in a Name? The Time Has Come to Unify Parkinson & apos;s Disease and Dementia with Lewy Bodies

Daniel Weintraub

MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial

Hubert H. Fernandez, Daniel Weintraub, Eric Macklin, Irene Litvan, Michael A. Schwarzschild, Jamie Eberling, Aleksandar Videnovic, Christopher J. Kenney

Summary: In patients with Parkinson disease dementia (PDD), SYN120 did not improve cognition significantly but showed potential benefits in cognitive activities of daily living and apathy.

PARKINSONISM & RELATED DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

Potentially inappropriate medications in older adults with Parkinson disease before and after hospitalization for injury

Thanh Phuong Pham Nguyen, Shelly L. Gray, Craig W. Newcomb, Qing Liu, Ali G. Hamedani, Daniel Weintraub, Sean Hennessy, Allison W. Willis

Summary: This study found that there were no significant differences in medication prescriptions between Parkinson disease (PD) patients hospitalized for serious injury and those hospitalized for other reasons, indicating a missed opportunity to deprescribe high-risk medications during care transitions.

PARKINSONISM & RELATED DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

Weight and survival after deep brain stimulation for Parkinson's disease

Robert S. Eisinger, Michael S. Okun, Stephanie Cernera, Jackson Cagle, Matthew Beke, Adolfo Ramirez-Zamora, B. Hope Kim, Daniel A. N. Barbosa, Liming Qiu, Pavan Vaswani, Whitley W. Aamodt, Casey H. Halpern, Kelly D. Foote, Aysegul Gunduz, Leonardo Almeida

Summary: Weight loss in Parkinson's disease patients accelerates before death. Patients who underwent deep brain stimulation surgery gained weight, and higher post-operative weight correlates with longer survival.

PARKINSONISM & RELATED DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

The Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP)

Vindhya Koneru, Alberto J. Espay, Allan J. Cole, Daniel Weintraub, Kathleen Crist, Maria B. Pascual, William G. Ondo

MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

What's in a Name? The Time Has Come to Unify Parkinson's Disease and Dementia with Lewy Bodies

Daniel Weintraub

MOVEMENT DISORDERS (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.